Your browser doesn't support javascript.
loading
CDK13 phosphorylates the translation machinery and promotes tumorigenic protein synthesis.
Wu, Chao; Xie, Ting; Guo, Ying; Wang, Donghai; Qiu, Min; Han, Ruyi; Qing, Guoliang; Liang, Kaiwei; Liu, Hudan.
Afiliação
  • Wu C; Department of Hematology, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, 430071, Wuhan, China.
  • Xie T; Frontier Science Center of Immunology and Metabolism, Wuhan University, 430071, Wuhan, China.
  • Guo Y; Department of Hematology, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, 430071, Wuhan, China.
  • Wang D; Frontier Science Center of Immunology and Metabolism, Wuhan University, 430071, Wuhan, China.
  • Qiu M; Frontier Science Center of Immunology and Metabolism, Wuhan University, 430071, Wuhan, China.
  • Han R; Frontier Science Center of Immunology and Metabolism, Wuhan University, 430071, Wuhan, China.
  • Qing G; Department of Pathophysiology, School of Basic Medical Sciences, Wuhan University, 430071, Wuhan, China.
  • Liang K; Frontier Science Center of Immunology and Metabolism, Wuhan University, 430071, Wuhan, China.
  • Liu H; Frontier Science Center of Immunology and Metabolism, Wuhan University, 430071, Wuhan, China.
Oncogene ; 42(16): 1321-1330, 2023 04.
Article em En | MEDLINE | ID: mdl-36882522
Cyclin-dependent kinase 13 (CDK13) has been suggested to phosphorylate RNA polymerase II and is involved in transcriptional activation. However, whether CDK13 catalyzes other protein substrates and how CDK13 contributes to tumorigenesis remain largely unclear. We here identify key translation machinery components, 4E-BP1 and eIF4B, as novel CDK13 substrates. CDK13 directly phosphorylates 4E-BP1 at Thr46 and eIF4B at Ser422; genetically or pharmacologically inhibiting CDK13 disrupts mRNA translation. Polysome profiling analysis shows that MYC oncoprotein synthesis strictly depends on CDK13-regulated translation in colorectal cancer (CRC), and CDK13 is required for CRC cell proliferation. As mTORC1 is implicated in 4E-BP1 and eIF4B phosphorylation, inactivation of CDK13 in combination with the mTORC1 inhibitor rapamycin further dephosphorylates 4E-BP1 and eIF4B and blocks protein synthesis. As a result, dual inhibition of CDK13 and mTORC1 induces more profound tumor cell death. These findings clarify the pro-tumorigenic role of CDK13 by direct phosphorylation of translation initiation factors and enhancing protein synthesis. Therefore, therapeutic targeting of CDK13 alone or in combination with rapamycin may pave a new way for cancer treatment.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Proteínas de Ciclo Celular Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Proteínas de Ciclo Celular Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China